Table 1.
a) | Dependency for daily activities due to comorbidities, different to deterioration from cancer. |
b) | Previous history of three or more of these comorbidities, even under control because of a correct treatment: |
□ Congestive heart failure | |
□ Other chronic cardiovascular diseases | |
□ Chronic obstructive pulmonary disease | |
□ Cerebrovascular disease | |
□ Peripheral neuropathy | |
□ Chronic renal failurea | |
□ Arterial hypertension | |
□ Diabetes mellitus | |
□ Systemic vasculitis | |
□ Severe arthritis | |
c) | At least one of these geriatric features: |
□ Age > 85 years | |
□ Fecal or urinary incontinence | |
□ Spontaneous bone fractures | |
□ Mild or moderate dementia | |
□ Frequent falls |
Patients must be frail and/or not candidates to receive polychemotherapy as defined by the presence of one or more of the three criteria (a, b, c). aHowever creatinine clearance should be > 30 mL/min for regorafenib treatment